Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Assembly Biosciences Inc
NASDAQ:ASMB
Assembly Biosciences Inc
NASDAQ:ASMB
Price:
20.86
USD
1.41%
Market Closed
Market Cap:
$413.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Assembly Biosciences Inc
NASDAQ:ASMB
|
US |
|
M
|
Maison Solutions Inc
NASDAQ:MSS
|
US |
|
C
|
Coca-Cola Consolidated Inc
SWB:CC5
|
US |
|
A
|
Attendo AB (publ)
STO:ATT
|
SE |
|
Flughafen Zuerich AG
F:UZAA
|
CH |
|
Kongsberg Gruppen ASA
F:KOZ1
|
NO |
|
A
|
Aspen Pharmacare Holdings Ltd
JSE:APN
|
ZA |
|
N
|
Northisle Copper and Gold Inc
OTC:NTCPF
|
CA |
|
A
|
Archer-Daniels-Midland Co
BMV:ADM
|
US |
|
G
|
Guardian Pharmacy Services Inc
NYSE:GRDN
|
US |
|
E
|
Equifax Inc
XMUN:EFX
|
US |
|
Bloomsbury Publishing PLC
F:5JZ
|
UK |
|
ReadCloud Ltd
ASX:RCL
|
AU |
Wall St Price Targets
ASMB Price Forecast
Based on 7 analysts
Based on 7 analysts
+154% Upside
from
$20.86
today
Assembly Biosciences Inc (ASMB)’s 12-month stock price forecast through October 2027 has a consensus target of $53.04, implying 154% upside. The forecast is based on price targets from 7 Wall Street analysts.
ASMB Analyst Rating
Based on 5 analysts
Based on 5 analysts
Analysts rate ASMB Strong buy, with 5 of 5 recommending Buy or Strong buy.
Assembly Biosciences Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ASMB's stock price target?
Price Target
53.04
USD
53.04
USD
According to Wall Street analysts, the average 1-year price target for ASMB is 53.04 USD with a low forecast of 43.43 USD and a high forecast of 65.1 USD.
What is the Revenue forecast for Assembly Biosciences Inc?
Projected CAGR
20%
20%
The compound annual growth rate for Revenue over the next 8 years is 20%.